Question 1

What are the differences between daily and episodic dosing of montelukast?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Intermittent and Daily Dosing for Episodic (Periodic) Asthma (0476-302)(COMPLETED) clinical trial (NCT00337675). Contact the study team or your healthcare provider for specific answers.

Question 2

How will we monitor my child's asthma symptoms during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Intermittent and Daily Dosing for Episodic (Periodic) Asthma (0476-302)(COMPLETED) clinical trial (NCT00337675). Contact the study team or your healthcare provider for specific answers.

Question 3

What side effects should we be aware of with montelukast?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Intermittent and Daily Dosing for Episodic (Periodic) Asthma (0476-302)(COMPLETED) clinical trial (NCT00337675). Contact the study team or your healthcare provider for specific answers.

Question 4

Are there any other treatment options we should consider alongside this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Intermittent and Daily Dosing for Episodic (Periodic) Asthma (0476-302)(COMPLETED) clinical trial (NCT00337675). Contact the study team or your healthcare provider for specific answers.

Question 5

How will participation in this trial affect my child's daily routine?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Intermittent and Daily Dosing for Episodic (Periodic) Asthma (0476-302)(COMPLETED) clinical trial (NCT00337675). Contact the study team or your healthcare provider for specific answers.

What this study is about